Advertisement

Table of Contents

January 01, 1989; Volume 35,Issue 1

You have access
Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
J M Musacchio, M Klein and J J Paturzo

Molecular Pharmacology January 1989, 35 (1) 1-5;
You have access
Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
S H Burstein, K Hull, S A Hunter and J Shilstone

Molecular Pharmacology January 1989, 35 (1) 6-9;
You have access
Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
J M Lunetta, K Sugiyama and M A Correia

Molecular Pharmacology January 1989, 35 (1) 10-17;
You have access
Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
J S Fine, T A Gasiewicz and A E Silverstone

Molecular Pharmacology January 1989, 35 (1) 18-25;
You have access
Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong

Molecular Pharmacology January 1989, 35 (1) 26-33;
You have access
Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
P C Francel, J F Keefer and G Dawson

Molecular Pharmacology January 1989, 35 (1) 34-38;
You have access
Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
M McKinney, D Anderson and L Vella-Rountree

Molecular Pharmacology January 1989, 35 (1) 39-47;
You have access
Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
S B Hwang, M H Lam and A H Hsu

Molecular Pharmacology January 1989, 35 (1) 48-58;
You have access
Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
M O Karlsson and A Neil

Molecular Pharmacology January 1989, 35 (1) 59-66;
You have access
Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak

Molecular Pharmacology January 1989, 35 (1) 67-74;
You have access
Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
C Czajkowski, T T Gibbs and D H Farb

Molecular Pharmacology January 1989, 35 (1) 75-84;
You have access
Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
C S Wu and J T Yang

Molecular Pharmacology January 1989, 35 (1) 85-92;
You have access
Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise

Molecular Pharmacology January 1989, 35 (1) 93-97;
You have access
Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
M A Vazquez-Padua, K Kunugi and P H Fischer

Molecular Pharmacology January 1989, 35 (1) 98-104;
You have access
Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
J M Ford, W C Prozialeck and W N Hait

Molecular Pharmacology January 1989, 35 (1) 105-115;
You have access
Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
J M Thomas and B B Hoffman

Molecular Pharmacology January 1989, 35 (1) 116-124;
You have access
Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
R F Cox and B L Waszczak

Molecular Pharmacology January 1989, 35 (1) 125-131;
You have access
Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
A H Cheung, I S Sigal, R A Dixon and C D Strader

Molecular Pharmacology January 1989, 35 (1) 132-138;
You have access
Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
P H Roseboom and M E Gnegy

Molecular Pharmacology January 1989, 35 (1) 139-147;
You have access
Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
J Halpert, J Y Jaw and C Balfour

Molecular Pharmacology January 1989, 35 (1) 148-156;
You have access
Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume

Molecular Pharmacology January 1989, 35 (1) 157-163;
You have access
Characterization of ligand binding to mitochondrial benzodiazepine receptors.
J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume

Molecular Pharmacology January 1989, 35 (1) 164-172;